A detailed history of Ascent Wealth Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ascent Wealth Partners, LLC holds 75,259 shares of PFE stock, worth $2.19 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
75,259
Previous 66,743 12.76%
Holding current value
$2.19 Million
Previous $1.85 Million 13.66%
% of portfolio
0.31%
Previous 0.27%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $215,114 - $252,073
8,516 Added 12.76%
75,259 $2.11 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $655,301 - $752,496
25,311 Added 61.09%
66,743 $1.85 Million
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $33,106 - $43,001
-1,267 Reduced 2.97%
41,432 $1.19 Million
Q3 2023

Oct 20, 2023

BUY
$32.09 - $37.51 $33,373 - $39,010
1,040 Added 2.5%
42,699 $1.42 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $55,263 - $63,938
1,530 Added 3.81%
41,659 $1.53 Million
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $64,008 - $83,330
1,625 Added 4.22%
40,129 $1.64 Million
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $72,979 - $95,266
1,748 Added 4.76%
38,504 $1.97 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $25,774 - $31,464
-589 Reduced 1.58%
36,756 $1.61 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $237,070 - $281,091
5,095 Added 15.8%
37,345 $1.99 Million
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $51,972 - $64,399
1,136 Added 3.65%
32,250 $1.67 Million
Q4 2021

Jan 27, 2022

BUY
$41.32 - $61.25 $82,020 - $121,581
1,985 Added 6.81%
31,114 $1.84 Million
Q3 2021

Nov 01, 2021

BUY
$39.25 - $50.42 $147,383 - $189,327
3,755 Added 14.8%
29,129 $1.25 Million
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $395,333 - $447,846
11,009 Added 76.64%
25,374 $994,000
Q1 2021

Apr 26, 2021

BUY
$33.49 - $37.77 $5,994 - $6,760
179 Added 1.26%
14,365 $520,000
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $7,463 - $9,490
223 Added 1.6%
14,186 $522,000
Q3 2020

Oct 22, 2020

BUY
$31.75 - $37.25 $20,859 - $24,473
657 Added 4.94%
13,963 $512,000
Q2 2020

Jul 21, 2020

SELL
$30.12 - $36.54 $1,807 - $2,192
-60 Reduced 0.45%
13,306 $435,000
Q1 2020

Apr 29, 2020

SELL
$27.03 - $38.62 $40,545 - $57,929
-1,500 Reduced 10.09%
13,366 $436,000
Q4 2019

Jan 29, 2020

SELL
$32.92 - $37.36 $2,896 - $3,287
-88 Reduced 0.59%
14,866 $582,000
Q3 2019

Oct 22, 2019

SELL
$32.49 - $42.13 $19,169 - $24,856
-590 Reduced 3.8%
14,954 $537,000
Q2 2019

Jul 30, 2019

SELL
$36.98 - $41.52 $6,471 - $7,266
-175 Reduced 1.11%
15,544 $673,000
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $22,612 - $24,843
-603 Reduced 3.69%
15,719 $668,000
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $14,810 - $16,886
-385 Reduced 2.3%
16,322 $712,000
Q3 2018

Aug 21, 2019

SELL
$34.47 - $41.81 $12,581 - $15,260
-365 Reduced 2.14%
16,707 $736,000
Q1 2018

Aug 21, 2019

BUY
$31.91 - $37.02 $41,993 - $48,718
1,316 Added 8.35%
17,072 $606,000
Q4 2017

Aug 21, 2019

BUY
$33.26 - $35.29 $20,621 - $21,879
620 Added 4.1%
15,756 $571,000
Q3 2017

Aug 21, 2019

SELL
$31.0 - $34.15 $1,550 - $1,707
-50 Reduced 0.33%
15,136 $540,000
Q1 2017

Aug 21, 2019

BUY
N/A
165 Added 1.1%
15,186 $520,000
Q4 2016

Aug 21, 2019

BUY
N/A
395 Added 2.7%
15,021 $488,000
Q3 2016

Aug 21, 2019

BUY
N/A
265 Added 1.85%
14,626 $495,000
Q2 2016

Aug 21, 2019

BUY
N/A
1,110 Added 8.38%
14,361 $506,000
Q1 2016

Aug 21, 2019

BUY
N/A
330 Added 2.55%
13,251 $393,000
Q3 2015

Aug 21, 2019

SELL
N/A
-41 Reduced 0.32%
12,921 $406,000
Q2 2015

Aug 21, 2019

BUY
N/A
41 Added 0.32%
12,962 $435,000
Q1 2015

Aug 21, 2019

SELL
N/A
-1,481 Reduced 10.28%
12,921 $450,000
Q4 2014

Aug 21, 2019

BUY
N/A
2,241 Added 18.43%
14,402 $449,000
Q3 2014

Aug 21, 2019

BUY
N/A
410 Added 3.49%
12,161 $360,000
Q2 2014

Aug 21, 2019

BUY
N/A
2,627 Added 28.79%
11,751 $349,000
Q4 2013

Aug 22, 2019

BUY
N/A
9,124
9,124 $279,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.